Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, Ro-associated Y1 pseudogene 11 (RNY1P11) is a human pseudogene derived from the RNY1 gene, part of the Ro-associated Y RNA family. Y RNAs are small noncoding RNAs involved in ribonucleoprotein complexes (Ro RNPs) and were originally identified by their association with autoantigen proteins implicated in autoimmune diseases such as lupus and Sjogren’s syndrome[2]. Unlike its parental gene, RNY1P11 is a pseudogene; it does not encode a functional RNA or protein product but may have regulatory functions at the RNA level, analogous to other pseudogenes that impact gene networks, miRNA availability, or cell signaling pathways. There is no direct evidence supporting therapeutic targeting, specific disease association, or use as a biomarker for RNY1P11[1][4][5].
none. No drugs target RNY1P11 specifically.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, Ro-associated Y1 pseudogene 11 (RNY1P11).